Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Hamza Gorsi, MD
Children's Hospital of Michigan
Study Chair - Maryam Fouladi, MD
Nationwide Children's Hospital
Principal Investigator - Susan Chi, MD
Dana-Farber Cancer Institute
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Sydney Children'S Hospital
Randwick, New South Wales, Australia
Not, yet, recruiting - Queensland Children'S Hospital
South Brisbane, Queensland, Australia
Not, yet, recruiting - Perth Children'S Hospital
Perth, Western Australia, Australia
Not, yet, recruiting
- the Hospital for Sick Children (sickkids)
Toronto, Ontario, Canada
Not, yet, recruiting - Montreal Children'S Hospital
Montreal, Quebec, Canada
Not, yet, recruiting
- Hopp Children'S Cancer Center at Nct Heidelberg (kitz)
Heidelberg, Baden-Wurttemberg, Germany
Not, yet, recruiting
- Princess Máxima Center
Utrecht, Netherlands
Not, yet, recruiting
- Starship Children'S Hospital
Auckland, Grafton, New Zealand
Not, yet, recruiting
- Children'S Hospital Colorado
Aurora, Colorado, United States
Not, yet, recruiting - Children'S National Medical Center
Washington D.C., District of Columbia, United States
Not, yet, recruiting - Ann & Robert H. Lurie Children'S Hospital of Chicago
Chicago, Illinois, United States
Not, yet, recruiting - Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Not, yet, recruiting - Duke University Health System
Durham, North Carolina, United States
Not, yet, recruiting - Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
Recruiting - Nationwide Children'S Hospital
Columbus, Ohio, United States
Recruiting - Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Not, yet, recruiting - Texas Children'S Hospital
Houston, Texas, United States
Not, yet, recruiting - Seattle Children'S Hospital
Seattle, Washington, United States
Not, yet, recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 3 Aug 2025
- Primary completion
- 1 Jul 2029
- Completion
- 1 Jun 2035
- Last update posted
- 29 Jun 2026
- Registered enrollment
- 15
- Registry id
- NCT06333899
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.